chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The first night I had a severe headache, but it was gone the next day, had no symptoms until yesterday, March 18th, after waking up with a huge rash all over my upper thighs and stomach, and the next day, March 19th, it had spread to my arms, and further down my legs, and is starting to spread to my face. No rash has appeared at the injection site, which led me to believe this wasn't a result of the vaccine, but I have made any behavior or diet changes, and have no known allergies, so the only thing I could think to cause the rash was due to the vaccine. I am not saying at all that this means I regret getting the vaccine, I just thought it would be responsible of me to report these symptoms, in case others were experiencing a delayed rash and was concerned. The rash hasn't caused any distress other than existing, there's no itching or pain from it, it just keeps spreading fairly rapidly.
Swelling and heat to (L) deltoid 1800 4/16. Took to ER 2200 pm, blood work obtained; IV Clindamycin given given as fever 100.6. 11:30 pm transferred to hospital. Admitted 48 hours with IVF and antibiotics. No fever since. Home on PO Clindamycin.
Exanthema and pruritus after 15 minutes receiving her first dose of the covid vaccine.
The excursion expiration date of 7 days thawed was followed because of the Pfizer email approving the 7 days. Walgreens policy was to follow the expiration of 5 days.
(L) upper arm swelling, warm to touch, itching, began 9/16/15, Tx is cool compress and BENADRYL.
Fever of 102, rash at injection site, redness at injection site, fussiness.
About an hour later I was very tired. When I woke up the next morning my arm hurt so bad I couldn?t lift higher than my shoulder. The pain was on the arm where my injection was and lasted about 3 days. I then had a red rash about the size of a tennis ball around the injection site for a week. 22 hours after my injection I was extremely lethargic and couldn?t do anything. I had to leave work. That lasted about 3 days. I felt like I had the flu.
Suspected vaccination failure; Shingles; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that they got the shingles from the shot. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and lab test confirmation were unknown at the time of reporting.
Approximately 10 minutes post vaccine administration bilateral lower eyelid swelling and runny nose noted. 15-20 minutes post administration marked peri orbital swelling noted. Allergic.
1 week after vaccine; patient complains of constant pain in deltoid muscle. no loss of range of motion detected. pain flares when muscle is used.
did not feel well; sick to my stomach; I couldn't function/had to stay in bed for a while; I had diarrhea for 3 to 4 days; chills; felt nauseated; I had really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (did not feel well), ABDOMINAL DISCOMFORT (sick to my stomach), HYPOKINESIA (I couldn't function/had to stay in bed for a while), DIARRHOEA (I had diarrhea for 3 to 4 days) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced MALAISE (did not feel well), ABDOMINAL DISCOMFORT (sick to my stomach), HYPOKINESIA (I couldn't function/had to stay in bed for a while), DIARRHOEA (I had diarrhea for 3 to 4 days), CHILLS (chills), NAUSEA (felt nauseated) and HEADACHE (I had really bad headache). On 24-May-2021, MALAISE (did not feel well), ABDOMINAL DISCOMFORT (sick to my stomach), HYPOKINESIA (I couldn't function/had to stay in bed for a while), DIARRHOEA (I had diarrhea for 3 to 4 days), CHILLS (chills), NAUSEA (felt nauseated) and HEADACHE (I had really bad headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took Advil before getting the 2nd dose of vaccine on 06-MAY-2021. Over-the-counter gas relief for stomach problems since the patient got the 2nd dose
TEMP 99.5 ON 12/30/20 TEMP 102.6 ON 12/31/20
Breakthrough COVID-19 case with Symptom onset  7/19/21; c/o cough, congestion, malaise. Death 8/3/2021. From vital records: HEART FAILURE UNSPECIFIED, ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS, COVID-19. Per vital records, COD ICD Codes include: Not yet coded ; Other Significant Conditions include: None listed. place of death: NURSING HOME-LONG TERM CARE FACILITY,, PRONOUNCING AND CERTIFYING PHYSICIAN; occ/ind: HOMEMAKER, OWN HOME
Needle was inserted into patient's arm and as the plunger of the syringe was being pushed down, the syringe and needle separated. The patient got less than half the dose and the rest went onto the floor after the two separated.
This case was reported by a nurse via call center representative and described the occurrence of bloating in a female patient who received ENGERIX B for prophylaxis. Concurrent medical conditions included allergy to grains. On an unknown date, the patient received the 1st dose of ENGERIX B. On an unknown date, unknown after receiving ENGERIX B, the patient experienced bloating and stomach discomfort. On an unknown date, the outcome of the bloating and stomach discomfort were unknown. It was unknown if the reporter considered the bloating and stomach discomfort to be related to ENGERIX B. Additional details reported as follows: The age at vaccination was not reported. The patient had an allergy to corn.
Pain, burning and swelling at injection site . Swelling of forearm with deep pain extending to heel of arm into thumb and little finger. Pain was so intense until 11:30 I was unable to sleep. Two days post-injection, injection site is still swollen, hot and hard to the touch. Overall, I am tired and headachy
both hands numb then tingling within 15-30 min post vaccination.  about 40 min post, right arm went completely numb briefly then tingling and feeling back within 2 minutes.   days 2 and 3 post vaccination, full body joint and muscle aching.  all symptoms resolved until 5 days post, horrible headache for 24 hrs. no issues since.
Migraine headache; This is a spontaneous report from a contactable nurse reporting for herself. A 38-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), intramuscular from 20Dec2020 11:00 in left arm to 20Dec2020 11:00 at single dose for COVID-19 immunization. Medical history was reported as none. Concomitant medication included cetirizine hydrochloride (ZYRTEC). On 20Dec2020 17:00, the patient experienced migraine headache approximately 6hrs after injection. The patient recovered on unspecified date. No treatment was given to the patient for the event. The facility where the most recent COVID-19 vaccine was administered was in the Public Health Clinic/Veterans Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The event was considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.
received a dose of the Moderna COVID-19 Vaccine that expired on July 25th; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th). On 27-Jul-2021, EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The reporter states the patient received a dose of the Moderna COVID-19 Vaccine that expired on 25 July 2021.  No concomitant medication were reported.  No treatment medication was reported.
dizziness  bp: 140/100 Pulse: 96 O2 99%   after 15 minutes   BP:136/94 Pulse 92   #21 went home
Patient received H1N1 Lot 102141P1 exp 4/10 on 1-11-2010 in left deltoid returned on 1-21-10 with sore arm and bruise approx 6 inches in diameter orange in color.
Report received from a pharmacist on 29-SEP-2010 (received via Merck - WAES: 1009USA05566). A 52 year old female patient (date of birth unknown) received AFLURIA (batch M50907, expiry 30-JUN-2011) for vaccination on 24-SEP-2010. The patient had no pertinent medical history or allergies. Concomitant medications were unknown. On 24-SEP-2010, the day of vaccination with the suspect drug, the patient experienced site pain, she had a bitter taste and within 15 minutes, she felt numbness and her throat closing. Paramedics were summoned. No medication was administered and the patient was released within 1 hour without further symptoms. The patient sought medical attention from the pharmacist. The event outcome was recovered on 24-SEP-2010. The reporter did not give a causality assessment. The company considered events possible in relation to the suspect drug. Information derived from this AE report does not change the current safety profile of the product.
Nausea, lightheadedness, abdominal cramps and blood in stool. There was also blood in stool 4 days after the first round of the vaccine but not with nausea and lightheadedness.
Approximately 20-25 min. post vaccination, employee reported chest tightness, flushing and light headed.  She was alert and oriented x 3.  V/S: 120/72; pulse 140; resp 22; O2 sat 99% on RA; pupils equal and reactive; skin pink. Dr was notified and assessed the employee.  Dr. ordered Benadryl 25mg PO which was administered at 1050.  1120 - o2 sat was 98% on RA; pulse 85; employee reported that chest tightness resolved and light headedness impoved, but not resolved; she continued to be flushed.  Symptoms continud to improve.  Employee remained in the observation area and was instructed to seek emergency treatment if symptoms returned, worsen or new symptoms occured.  She verbalized understanding.
At 1 pm temperature 99.5, clammy and pale and sleepy - given ibuprofen at 5 Pm mother noted upper lip swelling -given Benadryl  Blood sugars running unusually low for 24 hours
Vial refrigerated after expiry date; doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Vial refrigerated after expiry date) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial refrigerated after expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Vial refrigerated after expiry date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Date the vial was initially stored in the refrigerator was 18-Oct-2021. There was no temperature excursion. The reporter reported that that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.
The morning after her first vaccination she started having itching and what she describes as "hive type things" on arms and legs. They were very red and itchy, she treated with OTC Benadryl and was taking on and off until her second dose. The redness had started to fade by the time of her second dose. 2 days after the second dose the redness and itchiness got significantly worse on her arms and legs. It is worse on her arms than her legs, and the worst over her left arm where her vaccination was administered. She is also experiencing a lot of itching over her breasts but no redness or hives.  She is treating with OTC hydrocortisone cream and is going to start using Benadryl again.
Patient received dose #1 COVID-19 vaccine administration on 12/17/20. A day later on 12/18/20, patient experienced cold sweats, cough, body aches, fatigue, H/A, vomiting x2, chills, shaking, fatigue, and diarrhea.
fever over 101 for 36 hours, confusion, malaise, bp low 80/40 for 40 hours, headache right side
Swelling, rash and tenderness of the entire left anterior thigh; diagnosed as cellulitis and treated with Keflex.
Mild fever (100. 5), chills, congestion, diarrhea, headache, body aches
pt exp urticaria, erythema & warmth @ inject site w/in 24 hrs p/vax; no tx initiated; pt recovered;
DEATH!  FINDING:  Posterior right scalp hematoma. Additional right frontal/periorbital scalp hematoma. Mild scattered mucosal thickening in the paranasal sinuses. Air-fluid level in the right maxillary sinus. Mastoids aerated. Motion artifact limits evaluation of the globes and orbits, within this limitation the appear unremarkable. Calvarium intact. Low-density change involving nearly the entire left frontal lobe, left basal ganglia, left insula, anterior left parietal lobe, and superior left temporal lobe. There is associated loss of gray-white differentiation and is consistent with an acute to subacute subacute infarct. Measurements are approximately 4.7 x 11.0 cm. Foci of hyperdensity noted centrally within the tissue measuring up to 1.4 x 1.5 cm likely represents small amount of hemorrhage/hemorrhagic conversion. This involves both the left ACA and left MCA territories. Question hyperdensity within the left MCA. There is mass effect with sulcal effacement, compression of the left frontal horn/left lateral ventricle, and 2.5 mm rightward midline shift.     IMPRESSION:  1.  Large acute to subacute infarct measuring up to 4.7 x 11.0 cm involving nearly the entire left frontal lobe, left basal ganglia, left insula, superior left temporal lobe, and anterior left parietal lobe. This involves both the left anterior cerebral artery and left middle cerebral artery territories.  2.  Foci of hyperdensity centrally within the infarcted tissue is consistent with hemorrhage/hemorrhagic conversion. Largest focus of hemorrhage measures up to 1.5 cm.  3.  Together these findings contribute to mass effect with sulcal effacement, compression left lateral ventricle, and 2.5 mm rightward midline shift.  4.  Question hyperdense left MCA, presents potentially representing vascular occlusion or intravascular thrombus. CTA or MRA could provide further characterization.  5.  Posterior right and right frontal/periorbital scalp hematomas.
Patient was given IM HIB vaccine to left thigh that expired 8/12/23.
EXTREME VERTIGO; HARD SPOT AT INJECTION SITE; ARM WAS WEAK; INJECTION SITE PAINFUL 10 MONTHS LATER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced extreme vertigo, arm was weak, hard spot at injection site, and injection site painful 10 months later. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extreme vertigo, and the outcome of arm was weak, injection site painful 10 months later and hard spot at injection site was not reported. This report was non-serious.
itching on her hands, legs, calves, scalp and chest.; This is a spontaneous report from a contactable pharmacist.A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 1 via an unspecified route of administration on 08Mar2021 as DOSE 1, SINGLE for covid-19 immunization. Medical history included parkinson's disease from an unknown date and unknown if ongoing Parkinson's , chronic obstructive pulmonary disease, obesity from an unknown date and unknown if ongoing obese. The patient's concomitant medications were not reported.On an unspecified date the patient experienced itching on her hands, legs, calves, scalp and chest. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Report received from co-worker of patient. Patient received J&J vaccine on 3/13/21. Patient was at work and collapsed 11 days after vaccination.  Was intubated at work site and taken to local hospital - the patient was then airlifted to a Medcial Center.  Diagnosed with a brain bleed and subsequently died on 4/6/21.
On the morning of 3/11/2021 Patient experienced periods of confusion. slight loss of memory (couldn't remember where to turn to get to destination).  The episode lasted approximately 6-8 hours.  The remainder of the evening did not experience any symptoms previously described.
Some mild nausea; This is a spontaneous report from a contactable consumer.  A male patient of an unspecified age received BNT162B2, via an unspecified route of administration on 16Dec2020 at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced some mild nausea on 16Dec2020. The reporter indicated that the patient had some mild nausea that lasted for an hour or two but that it had completely passed.  The outcome of some mild nausea was recovered in Dec2020.      No follow-up attempts are possible; information about batch/lot number cannot be obtained.
I was in bed for 3 days due to coughing, upper respiratory issues, little appetite, fever, chills, and lack of energy. I tested positive for COVID-19. My doctor prescribed me PAXLOVID.
Headache, Myalgia, fever Narrative:  took tylenol  Other Relevant History:
Injection site {erythema warm sensation pain} with in 4 hrs of shot; then in 24 hrs --> pruritis + (increased) redness 5 treatment (resolved in 1 wk).
pt recvd vax OCT92 & exp fatigue, muscle aches, aching in spine, an elevated temp, nausea, h/a, anorexia & blurred vision;
Left arm has been affected including ongoing pain from shoulder to forearm. At first, I felt general soreness and discomfort, and after a few weeks pain and/weakness when lifting small  (coffee mug) and medium sized objects. Sometimes feels like nerve injury connecting deltoid, bicep and muscles of my forearm, even into my fingers. More recently, the pain feels focused in my shoulder. I have a general sensation of mild discomfort with shooting, stabbing pain when i try to perform certain actions. These flares are quite intense  and I'm unable to carry on with what I'm doing until it settles back down.
Got multiple boils and shingles-like rashes in both armpits, under breasts and groin areas. I have been getting 2 to 4 boils every month after taking the shots. Pharmacist directed me to use baking soda mixed with water to a paste and apply to affected areas.
Headache, fatigue, loss of appetite,  Lasted approx 6 hrs then ok
Patient was watching TV when she suddenly lost consciousness and slumped over, unresponsive. Bystander on scene describes some seizure like activity during event including: eyes rolling back in head and tensing and tremors in muscles. Patient regained consciousness after approximately 30 seconds.
Frequent chest Pain, periods are messed up. Nausea, terrible body ache, fever, chills, shaking. Same happened after 1st and 2nd shot as well. Took Advil to get fever down for 4-5 days. Body ache- very bad for 2 weeks (after 2nd and booster - 3rd shot)
On 08/18/2022, approximately 50 hours following receiving 0.5 mL of the Bavarian Nordic A/S Jynneos (PF) (Stockpile) vaccine via the subcutaneous route in the posterior left upper arm, I noticed pain at the site of the injection, along with a tender 2 cm subcutaneous firm nodule. At the same time, a pruritic well-marginated erythematous rash developed that lasted approximately 3 days and then resolved. At the time of this report, 08/27/2022, the tender subcutaneous nodule persists and the pain has improved greatly, although the nodule is still tender to touch.